Gitte‐Bettina Nyvang

Author

Odense University Hospital

Also Known As

G. Nyvang, G.B. Nyvang, Gitte-Bettina Nyvang, Gitte‐Bettina Nyvang, Nyvang, Gitte-Bettina

Publications

423

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Ludwig-Maximilians-Universität München Agostino Gemelli University Polyclinic Kliniken Essen-Mitte Aarhus University Hospital

About

Gitte‐Bettina Nyvang is an author at Odense University Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	309
2	Health Sciences	2	2	259
3	Obstetrics	2	2	96
4	Immunology	1	1	50
5	Pathology	1	1	50

Gitte‐Bettina Nyvang

Publications

406

Citations

H-Index

Page 1

	Year	Citations
From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Kari Tanderup, S.K. Nielsen, Gitte‐Bettina Nyvang, Radiotherapy and Oncology Cervical CancerMedical ImagingRadiation TherapyMedicineBrachytherapy	2010	213
Durvalumab with paclitaxel/carboplatin (PC) and bevacizumab (bev), followed by maintenance durvalumab, bev, and olaparib in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) without a tumor BRCA1/2 mutation (non-tBRCAm): Results from the randomized, placebo (pbo)-controlled phase III DUO-O trial. Philipp Harter, Fabian Trillsch, Aikou Okamoto, Journal of Clinical Oncology Surgical OncologyImmunologyImmunoeditingGynecologyPathology	2023	50
DUO-O: A randomized phase III trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients. Philipp Harter, Mariusz Bidziński, Nicoletta Colombo, Journal of Clinical Oncology Surgical OncologyTps5598 BackgroundCancer ManagementGynecologyPharmacotherapy	2019	46
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients Sara Bønløkke, Magnus Stougaard, Boe Sandahl Sørensen, Cells	2022	33
Trends in gynecologic cancer among elderly women in Denmark, 1980–2012 Anja Ør Knudsen, Doris Schledermann, Gitte‐Bettina Nyvang, Acta Oncologica	2016	28
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial Mansoor R. Mirza, Line Bjørge, Frederik Marmé, Gynecologic Oncology	2024	13
Circulating cell‐free HPV DNA is a strong marker for disease severity in cervical cancer Sara Bønløkke, Torben Steiniche, Boe Sandahl Sørensen, Molecular Oncology	2023	12
Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity Lea Milling Korsholm, Maj K. Kjeldsen, Lorenzo Perino, JCO Precision Oncology	2024	11

Page 1